TIME IN THERAPEUTIC RANGE (TTR): ANALYSIS IN A LARGE OBSERVATIONAL COHORT TAKING WARFARIN FOR CHADS2 MEASURED RISK IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS Academic Article uri icon